Available datapackage for study 'A Randomized, Double-blind, Placebo-Controlled Trial Comparing the Efficacy and Safety of Three Tirzepatide Doses Versus Placebo in Patients With Type 2 Diabetes, Inadequately Controlled With Diet and Exercise Alone'
收藏DataCite Commons2024-12-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/dataPackages/PR00008975.0
下载链接
链接失效反馈官方服务：
资源简介：
The goal for this study is to evaluate the efficacy and safety of tirzepatide versus placebo
in participants with type 2 diabetes not under control with diet and exercise alone. The
study will last approximately 47 weeks and may include about 15 visits.
提供机构：
Vivli
创建时间：
2024-03-27
